SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Panacea Biotec

BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 16:00
155.00
1.25 (0.81%)
VOLUME 10,554
LIVE
NSE
Feb 23, 15:53
155.10
1.65 (1.08%)
VOLUME 60,274
Announcements on Panacea Biotec

14th-Feb-2017 15:53Source: BSE

Panacea Biotec- Standalone Financial Results, Limited Review Report for December 31, 2016

Panacea Biotec Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Standalone Limited Review for the period ended December 31, 2016

24th-Jan-2017 16:47Source: BSE

Panacea Biotec- Board Meeting Intimation for Results & Closure of Trading Window

Panacea Biotec Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, inter alia, to consider and approve the Unaudited financial Re...

20th-Jan-2017 12:09Source: BSE

Panacea Biotec- Shareholding for the Period Ended December 31, 2016

Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly

18th-Jan-2017 12:39Source: BSE

Panacea Biotec- Panacea Biotec announces ANDA approval for US Market and LTA & Award from UN Agencies for Supply of Pentavalent Vaccine (Easyfive-TT)

Panacea Biotec Ltd has informed BSE regarding a Press Release dated January 18, 2017 titled "Panacea Biotec announces ANDA approval for US Market and LTA & Award from UN Agencies for Supply of Pentava...

18th-Jan-2017 12:20Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding a press release dated January 18, 2017, titled "Panacea Biotec announces ANDA approval for US Market and LTA & Award from UN Agencies for Sup...

15th-Jan-2017 10:21Source: BSE

Panacea Biotec- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

Panacea Biotec Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listi...

3rd-Jan-2017 10:44Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding a press release dated January 03, 2017, titled "Panacea Biotec ensures increased availability of Life saving Drug Cilamin 250 Capsules for tr...

3rd-Jan-2017 10:38Source: BSE

Panacea Biotec- Panacea Biotec Ensures Increased availability of Life Saving Drug Cilamin250 (D-Penicillamine IP 250mg) Capsules for Treatment of Wilson's disease in India

Panacea Biotec Ltd has informed BSE regarding a Press Release dated January 03, 2017 titled "Panacea Biotec Ensures Increased availability of Life Saving Drug Cilamin250 (D-Penicillamine IP 250mg) Cap...

26th-Dec-2016 11:24Source: NSE

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding press release dated December 26, 2016, titled "Panacea Biotec Introduces World's First Fully Liquid Tetravalent Vaccine Easyfour-TT against D...

26th-Dec-2016 11:04Source: BSE

Panacea Biotec- Panacea Biotec Introduces World's First Fully Liquid Tetravalent Vaccine Easyfour-TT against DTP and Hib

Panacea Biotec Ltd has informed BSE regarding a Press Release dated December 26, 2016 titled "Panacea Biotec Introduces World''s First Fully Liquid Tetravalent Vaccine Easyfour-TT against DTP and Hib"...

1 2 3 4 5 Next >>
Quick Links for Panacea Biotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.